These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 10963859)
41. The implementation of medical monitoring programs following potentially hazardous exposures: a medico-legal perspective. Vearrier D; Greenberg MI Clin Toxicol (Phila); 2017 Nov; 55(9):956-969. PubMed ID: 28644057 [TBL] [Abstract][Full Text] [Related]
42. Subchronic/chronic toxicity of a mixture of four chlorinated dibenzo-p-dioxins in rats. II. Biochemical effects. Viluksela M; Stahl BU; Birnbaum LS; Rozman KK Toxicol Appl Pharmacol; 1998 Jul; 151(1):70-8. PubMed ID: 9705888 [TBL] [Abstract][Full Text] [Related]
43. The significance of excursions above the ADI: duration in relation to pivotal studies. Walker R Regul Toxicol Pharmacol; 1999 Oct; 30(2 Pt 2):S114-8. PubMed ID: 10597624 [TBL] [Abstract][Full Text] [Related]
44. Effects of in utero and lactational TCDD exposure on bone development in differentially sensitive rat lines. Miettinen HM; Pulkkinen P; Jämsä T; Koistinen J; Simanainen U; Tuomisto J; Tuukkanen J; Viluksela M Toxicol Sci; 2005 Jun; 85(2):1003-12. PubMed ID: 15746008 [TBL] [Abstract][Full Text] [Related]
45. Hormesis: U-shaped dose responses and their centrality in toxicology. Calabrese EJ; Baldwin LA Trends Pharmacol Sci; 2001 Jun; 22(6):285-91. PubMed ID: 11395156 [TBL] [Abstract][Full Text] [Related]
46. Hormesis: why it is important to toxicology and toxicologists. Calabrese EJ Environ Toxicol Chem; 2008 Jul; 27(7):1451-74. PubMed ID: 18275256 [TBL] [Abstract][Full Text] [Related]
47. Crucial role of mechanisms and modes of toxic action for understanding tissue residue toxicity and internal effect concentrations of organic chemicals. Escher BI; Ashauer R; Dyer S; Hermens JL; Lee JH; Leslie HA; Mayer P; Meador JP; Warne MS Integr Environ Assess Manag; 2011 Jan; 7(1):28-49. PubMed ID: 21184568 [TBL] [Abstract][Full Text] [Related]
48. Acute toxicity in the guinea pig and in vitro "dioxin-like" activity of the environmental contaminant 1,2,4,5,7,8-hexachloro (9H)xanthene. DeCaprio AP; Briggs R; Gierthy JF; Kim JC; Kleopfer RD J Toxicol Environ Health; 1987; 20(3):241-8. PubMed ID: 3820338 [TBL] [Abstract][Full Text] [Related]
50. [Alternative methods to animal experiments. What can they afford in the safety testing of chemical substances under REACH?]. Lilienblum W Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2008 Dec; 51(12):1434-43. PubMed ID: 19137219 [TBL] [Abstract][Full Text] [Related]
51. Applications of computational toxicology methods at the Agency for Toxic Substances and Disease Registry. el-Masri HA; Mumtaz MM; Choudhary G; Cibulas W; De Rosa CT Int J Hyg Environ Health; 2002 Mar; 205(1-2):63-9. PubMed ID: 12018017 [TBL] [Abstract][Full Text] [Related]
52. From simple toxicological models to prediction of toxic effects in time. Sánchez-Bayo F Ecotoxicology; 2009 Apr; 18(3):343-54. PubMed ID: 19089613 [TBL] [Abstract][Full Text] [Related]
53. Physiologically based pharmacokinetic model for developmental exposures to TCDD in the rat. Emond C; Birnbaum LS; DeVito MJ Toxicol Sci; 2004 Jul; 80(1):115-33. PubMed ID: 15056810 [TBL] [Abstract][Full Text] [Related]
54. A research to develop a predicting system of mammalian subacute toxicity. II. Single dose detailed toxicity studies. Yamaguchi T; Watanabe T; Sako H; Isobe N; Nishimura H; Saito S; Shono F; Adachi H; Yabuki M; Shiba K; Matsuo M Chemosphere; 1996 Mar; 32(5):999-1019. PubMed ID: 8867145 [TBL] [Abstract][Full Text] [Related]
55. A critical review of time-weighted average as an index of exposure and dose, and of its key elements. Atherley G Am Ind Hyg Assoc J; 1985 Sep; 46(9):481-7. PubMed ID: 4050687 [TBL] [Abstract][Full Text] [Related]
56. Tox21 to date: steps toward modernizing human hazard characterization. Betts KS Environ Health Perspect; 2013 Jul; 121(7):A228. PubMed ID: 23816934 [No Abstract] [Full Text] [Related]
57. Time extrapolation and interspecies extrapolation for locally acting substances in case of limited toxicological data. Kalberlah F; Föst U; Schneider K Ann Occup Hyg; 2002 Mar; 46(2):175-85. PubMed ID: 12074027 [TBL] [Abstract][Full Text] [Related]
58. Human biomonitoring as a pragmatic tool to support health risk management of chemicals--examples under the EU REACH programme. Boogaard PJ; Hays SM; Aylward LL Regul Toxicol Pharmacol; 2011 Feb; 59(1):125-32. PubMed ID: 20933039 [TBL] [Abstract][Full Text] [Related]
59. TCDD toxicology with particular reference to Seveso: introductory remarks. Garattini S Drug Metab Rev; 1982; 13(3):345-53. PubMed ID: 7049639 [No Abstract] [Full Text] [Related]
60. Situations with enhanced chemical risks due to toxicokinetic and toxicodynamic factors. Dybing E; Søderlund EJ Regul Toxicol Pharmacol; 1999 Oct; 30(2 Pt 2):S27-30. PubMed ID: 10597610 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]